HCC patients with metastasis (n=81), portal vein tumor (n=45), vascular invasion (n=52) and advanced TNM stage (n=123) exhibited prominently increased CDK5 expression (P<0.01) (Table 1). This evidence concerns the gene CDK5 and hepatocellular carcinoma.